US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

98.73

+1.431.47%

Volume:7K

Turnover:644.33K

Market Cap:406.77M

PE:55.06

High:98.82

Open:97.68

Low:97.68

Close:97.30

52wk High:98.82

52wk Low:67.56

Shares:4.12M

Float Shares:4.12M

Volume Ratio:0.28

T/O Rate:0.16%

Dividend:1.55

Dividend Rate:1.57%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.64

PE(LYR):5.29

Loading ...

Overview Company News Filings

Biogen Files Form 3 Initial Beneficial Ownership Statement for Chief Legal Officer Michael Parini

Royalty Pharma and Zealand Pharma Enter into Rusfertide Funding Agreement for $100 Million

THOMSON REUTERS

Zealand Pharma Sells Rusfertide Royalty Interests to Royalty Pharma for USD 100 Million

Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says

MT Newswires Live

Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure

Is Alnylam’s Mixed 2026 Guidance Reset Altering The Investment Case For Alny (ALNY)?

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

Vertex 1Q Net Y772.00m vs Net Y658.00m

Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

Amgen to Open New Science & Innovation Center in Genome Valley, Hyderabad

THOMSON REUTERS

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors

Amgen’s AMG 355 Trial Completion: What This Early Cancer Study Means for AMGN Investors

Biogen’s Long-Term Spinraza Study Wraps Up, Setting the Stage for Key SMA Data

Global Drugmakers Invest Billions to Boost US Presence

Jefferies Remains a Buy on Vertex Pharmaceuticals (VRTX)

Royalty Pharma Publishes Transcript of Q2 2026 Financial Results Call

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

Vertex Pharmaceuticals Incorporated : Bofa Global Research Adds Stock to Its US 1 List

THOMSON REUTERS

Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development

Kailera Therapeutics Names Nur Nicholson Chief Technology Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PBE/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":98.7315,"timestamp":1787688000000,"preClose":97.301,"halted":0,"volume":6544,"delay":0,"changeRate":0.014701801625882518,"floatShares":4120000,"shares":4120000,"eps":1.793292,"marketStatus":"Pre-Mkt","change":1.4305,"latestTime":"08-26 04:00:00 EDT","open":97.68,"high":98.82,"low":97.68,"amount":644330.0273600001,"amplitude":0.011716,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":98.7315,"sharesOutstanding":3180000,"nav":97.25464,"aum":401661663.2,"dividendRate":0.01567,"bidAskSpread":0.002967,"postHourTrading":{"tag":"盘后","latestPrice":98.685,"preClose":98.7315,"latestTime":"19:30 EDT","volume":11,"amount":1086.1635,"timestamp":1787700601847,"change":-0.0465,"changeRate":-0.000471,"amplitude":0},"volumeRatio":0.28184543281111296,"impliedVol":0.1495,"impliedVolPercentile":0.076},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4120000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.28184543281111296,"shares":4120000,"dividePrice":1.5471,"high":98.82,"amplitude":0.011716,"preClose":97.301,"low":97.68,"week52Low":67.56,"pbRate":"1.64","psRate":"236.96","week52High":98.82,"institutionHeld":0.2552,"latestPrice":98.7315,"eps":1.793292,"divideRate":0.01567,"volume":6544,"delay":0,"ttmEps":1.793292,"open":97.68,"prevYearClose":82.15,"prevWeekClose":97.59,"prevMonthClose":89.6108,"prevQuarterClose":89.6486,"fiveDayClose":95.28,"twentyDayClose":91.7375,"sixtyDayClose":83.8038},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659218845","title":"Biogen Files Form 3 Initial Beneficial Ownership Statement for Chief Legal Officer Michael Parini","url":"https://stock-news.laohu8.com/highlight/detail?id=2659218845","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659218845?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:51","pubTimestamp":1786567875,"startTime":"0","endTime":"0","summary":"Biogen files Form 3 initial beneficial ownership statement for Chief Legal Officer Michael PariniBiogen filed a Form 3 showing Chief Legal Officer Michael Parini as a reporting insider as of Aug. 3, 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL2TBNSt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4532","IE00B894F039.SGD","LU0234570918.USD","LU0889565916.HKD","PBE","BIIB","BMED","IE00B19Z9Z06.USD","LU0109394709.USD","IE00B19Z9P08.USD","LU0320765992.SGD","BK4139","BK4588","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659070939","title":"Royalty Pharma and Zealand Pharma Enter into Rusfertide Funding Agreement for $100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659070939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659070939?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:10","pubTimestamp":1786565400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA7DFJ4P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IHE","BK4007","RPRX","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659074339","title":"Zealand Pharma Sells Rusfertide Royalty Interests to Royalty Pharma for USD 100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659074339","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659074339?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565156,"startTime":"0","endTime":"0","summary":"Zealand Pharma sells rusfertide royalty interests to Royalty Pharma for USD 100 millionZealand Pharma sold its economic interests tied to rusfertide to Royalty Pharma for USD 100 million in a royalty ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL6vP8kn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4588","SG9999014039.USD","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","PBE","IE00BN0W2V16.EUR","LU0314104364.USD","BK4585","LU2210150020.SGD","SG9999014021.USD","IHE","BK4007","SG9999014013.SGD","NDAQ","BCDF","RPRX","IE00BN0W2T93.GBP","BK4112","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658290503","title":"Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658290503","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658290503?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:02","pubTimestamp":1786546971,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  has multiple potential catalysts coming from its portfolio that provide a net positive risk-reward profile for the company, RBC Capital Markets said in a Wednesday note.The company is expected to present results from its phase 1 study of VX-828 in patients with cystic fibrosis in H2, with a positive readout potentially strengthening its competitive advantage in the space, RBC analysts said.Favorable data will likely result in modest upside, while unfavorable data will likely lead to little downside, the analysts added.Meanwhile, approval by the US Food and Drug Administration for Vertex's povetacicept in immunoglobulin A nephropathy, with a PDUFA date of Nov. 30, 2026, is likely due to strong interim phase 3 results, the analysts said.They said that the drug's differentiated profile could make it the preferred choice of most doctors.With Sionna Therapeutics  failing to demonstrate significant sweat chloride improvements as an add-on to Trikafta, one of the more ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0058720904.USD","VRTX","BK4585","SGXZ57979304.SGD","LU0566484027.USD","BBH","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","BIB","SION","IDNA","LU0061475181.USD","BK4023","LU0109394709.USD","BK4532","LU1815336091.USD","TBXU","BK4139","LU0417517546.SGD","IE00BJJMRZ35.SGD","LU1674673691.USD","IBBQ","LU2417539215.USD","IE00B19Z3581.USD","IE00B19Z9Z06.USD","LU2237438978.USD","LU2324357040.USD","PBE","IE00B2B36J28.USD","LU2362541273.HKD","SG9999013999.USD","LU1069344957.HKD","GNMX","BK4567","IBB","IE00BZ9MQY76.HKD","LU2362540622.SGD","LU2456880835.USD","IE00BFTCPJ56.SGD","LU1559883803.SGD","LU1430594728.SGD","LU2362541513.USD","LU1093756325.SGD","VERX","LU1778281490.HKD","LU0079474960.USD","BK4588","BK4533","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142463773","title":"Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=1142463773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142463773?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:10","pubTimestamp":1786543834,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) issued a statement on August 12, revealing that its stock price has experienced an unusual surge, with cumulative closing price gains exceeding...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBP","APXH","LFSC","GSKH","PBE","BK0102","BK0216","WRND","BK4585","XLVI","600721","SBIO","BIOY","IBB","BK4588","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908275","title":"Is Alnylam’s Mixed 2026 Guidance Reset Altering The Investment Case For Alny (ALNY)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908275","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908275?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:26","pubTimestamp":1786537582,"startTime":"0","endTime":"0","summary":"In the second quarter of 2026, Alnylam Pharmaceuticals reported revenue of US$1,290.95 million and net income of US$164.49 million, a shift from a net loss a year earlier, and for the first half of 2026 revenue reached US$2,458.12 million with net income of US$370.49 million. \nOn the same day, the company trimmed its full-year 2026 guidance for total net product revenues while raising expectations for collaboration and royalty income, highlighting a changing balance between its own drug...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/is-alnylams-mixed-2026-guidance-reset-altering-the-investmen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/is-alnylams-mixed-2026-guidance-reset-altering-the-investmen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0114720955.EUR","BK4548","PBE","LU0109394709.USD","BK4585","GNMX","BK4139","LU0320765992.SGD","LU0882574055.USD","LU0889565916.HKD","ALNY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974863","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974863?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:10","pubTimestamp":1786533037,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Brookdale Senior Livi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1499592464.USD","LU0234570918.USD","IE0002270589.USD","LU1778281490.HKD","LU2468319806.SGD","SG9999001176.USD","BK4532","LU0079474960.USD","GNMX","TBXU","LU0417517546.SGD","LU0058720904.USD","LU0061475181.USD","HCSG","LU1815336091.USD","LU0757428866.USD","LU2417539215.USD","IE00B894F039.SGD","LU0029874061.USD","BIB","IE00B19Z3581.USD","BK4505","XLV","XBI","IE00BZ9MQY76.HKD","LU1430594728.SGD","LU2237438978.USD","LU0432979614.USD","BKD","BBH","PBE","IBBQ","LU1035775433.USD","BK4185","LU2089984988.USD","IE00B19Z3B42.SGD","BK4588","LU2462157665.USD","MEMS","LU1674673691.USD","MEDI","LU1585245621.USD","SG9999001176.SGD","VERX","VRTX","CANC","IBB","IDNA","LEGN","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658414920","title":"Vertex 1Q Net Y772.00m vs Net Y658.00m","url":"https://stock-news.laohu8.com/highlight/detail?id=2658414920","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658414920?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:41","pubTimestamp":1786524060,"startTime":"0","endTime":"0","summary":"Results are based on Japanese accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0009355771.USD","LU0432979614.USD","BIB","GNMX","LU0079474960.USD","LU1778281490.HKD","IDNA","IBB","SG9999013999.USD","LU0058720904.USD","LU0823416689.USD","LU1430594728.SGD","LU1674673428.USD","SGXZ57979304.SGD","LU1815336091.USD","VERX","LU0757428866.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","BK4023","IE00B4R5TH58.HKD","IE00B894F039.SGD","LU1674673691.USD","LU0234570918.USD","BBH","LU1035775433.USD","SG9999001176.USD","VRTX","LU2362541513.USD","LU0566484027.USD","BK4585","IE0002141913.USD","BK4588","LU1093756325.SGD","LU2456880835.USD","SG9999001176.SGD","LU2237438978.USD","LU0289739699.SGD","TBXU","PBE","LU2462157665.USD","LU0256863811.USD","IE00BZ9MQY76.HKD","BK4567","IE00B19Z9P08.USD","IBBQ","LU2089984988.USD","LU2468319806.SGD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658920953","title":"Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920953","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658920953?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:33","pubTimestamp":1786523580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 1.5% to 4.93 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.8% to 25440.17.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 46% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.3% and Amgen Inc. remained unchanged.Trading volume totaled 51.4 million shares, compared to the 50-day average of 99.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00B2B36J28.USD","BK4599","LU0289739699.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2468319806.SGD","BK4566","BK1191","IE00BZ08YT58.USD","AMGN","LU0320765992.SGD","LU0109394709.USD","LU2242646821.SGD","BK4581","IBB","IE00BZ08YR35.GBP","BK4585","TBXU","01177","IE00BJJMRZ35.SGD","BK4139","SG9999001440.SGD","IE00BZ08YS42.EUR","LU1061106388.HKD","BK4588","HK0000165453.HKD","LU0058720904.USD","LU0868494617.USD","LU2112291526.USD","PBE","LU2242652126.USD","PJP","LU1571399168.USD","IE0002141913.USD","BK1521","BK4533","BK1515","BBH","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1983299246.USD","LU2089984988.USD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IBBQ","LU1057294990.SGD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658277549","title":"Amgen to Open New Science & Innovation Center in Genome Valley, Hyderabad","url":"https://stock-news.laohu8.com/highlight/detail?id=2658277549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658277549?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:26","pubTimestamp":1786523176,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBXU","LU2242646821.SGD","BBH","SG9999001440.SGD","LU2242652126.USD","LU0889565916.HKD","BK4533","IE00BJJMRZ35.SGD","AMGN","LU1061106388.HKD","LU1983299246.USD","IE0002141913.USD","BK4566","BK4534","LU2089984988.USD","IBBQ","BK4599","LU0320765992.SGD","LU0289739699.SGD","LU1571399168.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU2468319806.SGD","BK4139","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4581","LU1057294990.SGD","LU0122379950.USD","IE0009355771.USD","IBB","PJP","BK4585","PBE","LU0109394709.USD","BIB","BK4588","LU0868494617.USD","LU2112291526.USD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945241","title":"Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945241","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945241?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:00","pubTimestamp":1786482000,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  slipped 1.56% to $203.89 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.32% to 7,728.20 and Dow Jones Industrial Average  falling 0.34% to 53,791.85.This was the stock's second consecutive day of losses.Biogen Inc. closed 7.20% below its 52-week high of $219.72, which the company achieved on June 29th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 0.77% to $259.80, Pfizer Inc.  fell 1.59% to $26.62, and AbbVie Inc.  rose 0.85% to $250.09.Trading volume  remained 329,545 below its 50-day average volume of 1.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 11, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU0889565916.HKD","LU0109394709.USD","BMED","IE00B19Z9Z06.USD","BK4532","IE00B894F039.SGD","LU0320765992.SGD","BIIB","PBE","IE00B19Z9P08.USD","BK4533","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658147129","title":"Amgen’s AMG 355 Trial Completion: What This Early Cancer Study Means for AMGN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658147129","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658147129?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:30","pubTimestamp":1786465821,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has completed a first-in-human trial of AMG 355 in advanced solid...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-amg-355-trial-completion-what-this-early-cancer-study-means-for-amgn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-amg-355-trial-completion-what-this-early-cancer-study-means-for-amgn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","LU1023059063.AUD","TBXU","LU2242646821.SGD","LU1057294990.SGD","IBB","IE00B64PRP62.GBP","PBE","BK4581","SG9999001440.SGD","LU2112291526.USD","BK4566","AMG","BK4599","IE0002141913.USD","ISBC","IE00B2B36J28.USD","LU0109394709.USD","LU1061106388.HKD","BK4534","IE00BFTCPJ56.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","AMGN","BK4135","LU0058720904.USD","BK4585","IBBQ","BK4211","IE00B4R5TH58.HKD","BK4588","IE00B3QW5Z07.USD","BK4533","BBH","LU0889565916.HKD","IE0009355771.USD","BK4505","LU0289739699.SGD","LU1983299246.USD","PJP","IE00BGHQF748.EUR","LU1571399168.USD","LU2242652126.USD","BK4139","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658914794","title":"Biogen’s Long-Term Spinraza Study Wraps Up, Setting the Stage for Key SMA Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2658914794","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658914794?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:30","pubTimestamp":1786465814,"startTime":"0","endTime":"0","summary":"Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Biogen Inc. (BIIB) has completed a long-term Phase 3 extension study of hi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biogens-long-term-spinraza-study-wraps-up-setting-the-stage-for-key-sma-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biogens-long-term-spinraza-study-wraps-up-setting-the-stage-for-key-sma-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4217","BK4532","BMED","LU0234570918.USD","BK4139","IE00B19Z9P08.USD","BK4533","LU0889565916.HKD","LU0109394709.USD","BK4585","BK4588","IE00B19Z9Z06.USD","LU0320765992.SGD","PBE","SMA","BIIB","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911015","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911015?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:57","pubTimestamp":1786463857,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 11 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N44815K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","LU0320765489.SGD","LU1196500208.SGD","LU0124676726.USD","LU1066051811.HKD","IE00BFSS7M15.SGD","LU1035775433.USD","LU1670711040.USD","LU2264538146.SGD","LU2125909247.SGD","LU0889565916.HKD","LU0096364046.USD","LU1989772923.USD","SG9999015945.SGD","LU0130517989.USD","LU0130102774.USD","SG9999014575.USD","LU0158827781.USD","LU0640476718.USD","LU0726765562.USD","LU2471134879.HKD","LU2237443382.USD","LU0234572021.USD","BK4550","IE00B42XCP33.USD","SG9999001440.SGD","LU0203201768.USD","VHT","LU1093756325.SGD","LU0672654240.SGD","LU1989771016.USD","XLV","LU1116320901.HKD","IE00BDGV0183.EUR","ELIS","LU2111349929.HKD","BK7067","LU2357305700.SGD","IE0009355771.USD","TBXU","LU1934455194.USD","LU2462591350.SGD","SG9999011175.SGD","LU2361044865.SGD","IE00BBT3K403.USD","LU0162691827.USD","LU1814569148.SGD","IE00BLSP4239.USD","LU0289739699.SGD","LU0859254822.USD","CANC","LU0395794307.EUR","LU1548497426.USD","PPH","LU1201861249.SGD","LU0203347892.USD","LU2456880835.USD","LU0345769128.USD","LU0306807586.USD","MHIP","NVO","BK4592","PAWZ","LU1868836757.USD","LU2028103732.USD","IE000MB6IJN5.SGD","LU1670628061.USD","LU0661504455.SGD","LU0456855351.SGD","IE000BZT7R73.USD","IE0002141913.USD","LU1221951129.SGD","LU0098860793.USD","LU0057025933.USD","IE00B19Z9P08.USD","LU0426417589.USD","LU0310799852.SGD","LU0787776722.HKD","LU2237443978.SGD","LU0321505868.SGD","BK4581","IE0005OL40V9.USD","BK4534","LLYX","LU2491050071.SGD","IE00BN8TJ469.HKD","LU1935042991.SGD","LU0234570918.USD","LU0472753341.HKD","IE00B3PB1722.GBP","LU0198837287.USD","LU1221951046.USD","LU1506573853.SGD","LU1868837136.USD","LU1778281490.HKD","BK4559","LU0029864427.USD","LU1674673691.USD","LU1496350171.SGD","LU1035773651.USD","IE00BSNM7G36.USD","LU2087621335.USD","LU0211327993.USD","LU0266013472.USD","LU2063271972.USD","LU1267930573.SGD","IE000SO60NU8.SGD","LU0053666078.USD","LU2433249047.HKD","BK7508","LU0545562505.USD","LU0466842654.USD","LU0203345920.USD","LU1232071149.USD","LU0203202063.USD","LU1670710661.SGD","IE00BFXG1179.USD","SNY","SGXZ57979304.SGD","LU2129689605.HKD","LU2347655156.SGD","LU0708994859.HKD","LU2403377893.USD","SG9999014567.USD","LU1868836591.USD","IE00B4R5TH58.HKD","SG9999003800.SGD","LU0006306889.USD","LU0058720904.USD","LU0353189763.USD","AMGN","IE00B4JS1V06.HKD","LU0985481810.HKD","LU2237443549.SGD","IXJ","LU0069063385.USD","IHE","LU2133065610.SGD","LU1267930813.SGD","HRTS","LU1093756168.USD","LU0820561909.HKD","LU0980610538.SGD","IE00B19Z3581.USD","LU0225283273.USD","LU2360032135.SGD","LU0861579265.USD","SG9999002232.USD","IE00BJJMRY28.SGD","LU0316494557.USD","LU2361044949.HKD","LU2471134796.USD","SG9999017495.SGD","LU0477156953.USD","LU0122379950.USD","LU1037948541.HKD","PBE","LU2168564065.EUR","LU2242652126.USD","LU0323591593.USD","ILDR","LU2106854487.HKD","GSKH","LU0210536198.USD","IE00BGHQF631.EUR","LU2430703178.SGD","LU1804176565.USD","LU0256863902.USD","LLYZ","IE0004445239.USD","LU0471298694.HKD","SGXZ51526630.SGD","LU0882574139.USD","SG9999015341.SGD","LU0225771236.USD","LU0786609619.USD","LU0882574055.USD","IE00B1BXHZ80.USD","LU2487616109.SGD","LU0471298777.SGD","SG9999002224.SGD","IE00BJLML261.HKD","03165","LU0094547139.USD","LU1066051498.USD","LU0417517546.SGD","LU0174119429.USD","LU1032466523.USD","IE000M9KFDE8.USD","IE00B3T34201.USD","LU1732799900.SGD","LU1430594728.SGD","LU2211815571.USD","LU2746668974.SGD","LU0265550359.USD","LU2168564495.EUR","LU2750360641.GBP","IBBQ","LU1670710588.SGD","BK4599","LU2357627491.SGD","IE00BKVL7J92.USD","LU1894683264.USD","LU2168563687.JPY","PFE","LLII","LU2168564222.USD","IE00BLSP4452.SGD","LU1929549753.HKD","LU2237443622.USD","LU0354030511.USD","SG9999018865.SGD","LU1629891620.HKD","LU0943347566.SGD","LU2491049909.HKD","IE00BWXC8680.SGD","LU1720051108.HKD","LU1066053197.SGD","LU1074936037.SGD","LU0211328371.USD","LU1291159041.SGD","LU1989772840.SGD","LU2023250504.SGD","LU2242646821.SGD","SG9999001176.SGD","LU1069347547.HKD","AZN","LU1061106388.HKD","LU1244550221.USD","TMED","BK4516","BIB","LU2756315318.SGD","LU0823434740.USD","LU0320765646.SGD","LU2023250843.SGD","SG9999015358.SGD","RHHBY","SG9999014906.USD","JNJ","SG9999018857.SGD","LU0345770308.USD","LU0683600562.USD","LU0097036916.USD","LU0354030438.USD","LU1670711123.USD","BK4139","IE00BN29S564.USD","IE00BVYPNW00.USD","LU1366192091.USD","LU2462157665.USD","LU0079474960.USD","BK4583","BK4504","MRK","IE00BFTCPJ56.SGD","LU2089984988.USD","IE00BJT1NW94.SGD","LU2112291526.USD","LU0072461881.USD","AGNG","LU1043141396.HKD","LU1829250122.USD","LU2237443895.HKD","RXL","LU1699723380.USD","LU0965509010.AUD","LU1712237335.SGD","LU2471134952.CNY","LU2602419157.SGD","LU1069344957.HKD","LU0210528500.USD","PJP","LU0994945656.USD","SGXZ99366536.SGD","LU0225284248.USD","LU0267386448.USD","LU2125154778.USD","LU1057294990.SGD","IE00B894F039.SGD","LU0868494617.USD","LU0648001328.SGD","IE00BK4W5M84.HKD","IBB","GLAM","IE0034235303.USD","LU0823434583.USD","LU0985320562.USD","JDOC","LU0133085943.USD","NVOX","LU0061475181.USD","LU2756315664.SGD","SG9999015986.USD","LU1244550577.SGD","LU2129689514.USD","LU1032955483.USD","BMY","LU2461242641.AUD","OZEM","LU1127390331.HKD","LU1551013425.SGD","LU0820562030.AUD","IE00BK4W5L77.USD","LU2750360997.AUD","LU1623119135.USD","LU2087625088.SGD","IE0000B7K699.USD","LU1983299246.USD","LU0211331839.USD","BMED","LU1571399168.USD","NVOH","LU1868837300.USD","LU0385154629.USD","SG9999014542.SGD","SG9999001176.USD","LU0289739343.SGD","LU0689472784.USD","LU2125154935.USD","LU1868836914.USD","LU0158827948.USD","LU2596442595.SGD","LU1003077747.HKD","LU0128525929.USD","LU1914381329.SGD","LU0823416689.USD","LU1267930730.SGD","IE00B19Z9Z06.USD","LU0426412945.USD","LU2347655073.USD","LU0553294199.USD","LU2125909593.SGD","LU2896262040.SGD","LU1145028129.USD","LU0511384066.AUD","LU1720051017.SGD","LU2417539215.USD","LU1064131342.USD","LU0106261372.USD","LLY","LU1670627923.USD","LU0820561818.USD","IE00B1XK9C88.USD","LU0965509101.SGD","LU0432979614.USD","BK4578","LU2468319806.SGD","LU0795875169.SGD","LU2592432038.USD","LU2271345857.HKD","LU0109391861.USD","LU2213496289.HKD","LU0320765059.SGD","LU1267930490.SGD","IE0002270589.USD","LU2236285917.USD","ABBV","LU2023250330.USD","LU0109394709.USD","LU0889566641.SGD","FTXH","LU1228905540.USD","LU1674673428.USD","LU2168564149.EUR","MEDI","LU2505996681.GBP","LU0792757196.USD","IE00BKDWB100.SGD","LU2237438978.USD","MEDX","LU0689626769.HKD","LU1037948897.HKD","LU2089284900.SGD","BIIB","LU2265009873.SGD","LU1116320737.USD","SG9999014914.USD","LU2324357040.USD","LU1323610961.USD","BK4533","LU1732800096.USD","LU1228905037.USD","LU0912757837.SGD","LU0310800379.SGD","LU0738911758.USD","BBH","LU0070302665.USD","LU1979441026.SGD","LU1988902786.USD","IE00B19Z3B42.SGD","LU1066051225.USD","BK4585","LU0170899867.USD","LU2552382132.HKD","LU2361045086.USD","LU2552382215.SGD","SGXZ31699556.SGD","LU0320765992.SGD","LU2023251221.USD","IE0001KFT4U8.USD","LU1551013342.USD","04332","LU0289961442.SGD","LU2746668461.USD","LU0345769631.USD","NVS","SG9999015978.USD","IE00BJJMRX11.SGD","GB00BDT5M118.USD","LU1934455863.HKD","SG9999015952.SGD","BK7501","LU1244550494.USD","LU2491050154.USD","LU0154236417.USD","LU2108987350.USD","GILD","AZNH","LU1923622614.USD","LU0070217475.USD","BK4568","IE000F7OJYX1.SGD","WDNA","IE00BJJMRZ35.SGD","LU1883839398.USD","BK7511","SG9999014880.SGD","GSK","LU0306806265.USD","ELIL","LU0208291251.USD","IE000WAW04H5.SGD","TRUH","BK4588","LU1974910355.USD","LU1894683348.USD","LU0321505439.SGD","LU0964807845.USD","CSL.AU","LU0795875086.SGD","LU0256863811.USD","LU2505996509.AUD","BK4566","SG9999014559.SGD","LU0965508806.USD","LU0965509283.SGD","LU1023059063.AUD","LU1496350502.SGD","LU2471134523.USD","IE00B7SZLL34.SGD","IYH","LU2430703251.USD","LU0942090050.USD","LU2360106947.USD","IE00B775H168.HKD","SG9999013999.USD","CURE","LU0708995401.HKD","SG9999014898.SGD","LU0949170772.SGD","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU0545039389.USD","LU1839511570.USD","LU1280957306.USD","IE0004445015.USD","LU1941712348.USD","LU2430703095.HKD","LU0237698245.USD","LU2237443465.HKD","LU0353189680.USD","LU1585245621.USD","LU1917777945.USD","IE00BKPKM429.USD","LU1941712264.USD","BK4007","LU0345770993.USD","IE00B7KXQ091.USD","SGXZ80539844.SGD","IE00B2B36J28.USD","LU1261432733.SGD","IE00BVYPNV92.GBP","GSK.UK","LU0868494708.USD","GDOC","LU1718418525.SGD","LU1059921491.USD","LU2552382058.USD","THNR","BK4532","LU1043141123.HKD","LU1121112475.USD","LU0238689110.USD","LU1934455277.USD","FHLC","LU2089283258.USD","LU1162221912.USD","IE00BFSS8Q28.SGD","SGXZ81514606.USD","LU0265550946.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919006","title":"Jefferies Remains a Buy on Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919006?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:56","pubTimestamp":1786460205,"startTime":"0","endTime":"0","summary":"Jefferies analyst Akash Tewari maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $633.00. According to TipRanks, Te...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","BK4139","LU2089984988.USD","SG9999001176.USD","LU1778281490.HKD","LU1430594728.SGD","PBE","LU0061475181.USD","IBBQ","IDNA","LU0757428866.USD","IE00B19Z9P08.USD","LU2324357040.USD","LU0289739699.SGD","LU0889565916.HKD","LU2236285917.USD","BIB","BK4023","SG9999013999.USD","GNMX","IE0002141913.USD","LU1093756168.USD","LU0566484027.USD","LU2237438978.USD","LU2462157665.USD","LU0432979614.USD","SGXZ57979304.SGD","LU2362541273.HKD","IE00B2B36J28.USD","LU0256863811.USD","LU1069344957.HKD","IE00BFTCPJ56.SGD","BK4533","LU0234570918.USD","BBH","LU2417539215.USD","IE00B19Z9Z06.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IBB","LU1815336091.USD","LU2362541513.USD","VRTX","IE00B894F039.SGD","LU0058720904.USD","LU0320765992.SGD","BK4585","LU2468319806.SGD","VERX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916886","title":"Royalty Pharma Publishes Transcript of Q2 2026 Financial Results Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916886","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658916886?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:58","pubTimestamp":1786456727,"startTime":"0","endTime":"0","summary":"Royalty Pharma publishes transcript of Q2 2026 financial results callRoyalty Pharma’s Q2 2026 results call drew CEO Pablo Legorreta, EVP Marshall Urist, Chairman of Partnering & Investments Christophe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL79wbJH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0528227936.USD","RPRX","BK4581","LU2111349929.HKD","LU1988902786.USD","LU0052756011.USD","LU0267386448.USD","GSX","LU0942090050.USD","LU0320765646.SGD","LU0098860793.USD","LU2089283258.USD","LU2237443895.HKD","BK4534","BK4533","LU0234570918.USD","KBWB","LU0106831901.USD","LU1506573853.SGD","LU2357305700.SGD","LU2487616109.SGD","LU1064131342.USD","BK4552","LU2236285917.USD","LU0477156953.USD","LU2456880835.USD","LU2471134952.CNY","LU0061475181.USD","LU2237443382.USD","LU0162691827.USD","LU2237443622.USD","LU0882574139.USD","LU0310800965.SGD","EVR","FTXO","LU1732800096.USD","IHE","PBE","LU1791710582.SGD","LU0203347892.USD","IE0002270589.USD","BK4585","IYF","BK4566","LU2462157665.USD","LU2360032135.SGD","LU0912757837.SGD","LU0170899867.USD","TFNS","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658913504","title":"Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658913504","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658913504?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:00","pubTimestamp":1786453226,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0417517546.SGD","METV","GEHC","BK4139","LU0267386448.USD","LU1261432733.SGD","LU1559883803.SGD","GE","XAR","UXI","ITA","LABU","LU0353189680.USD","LU1093756325.SGD","LU2756315318.SGD","DFEN","NATO","GNMX","IE0009355771.USD","LU2089984988.USD","EXI","LU0058720904.USD","LU2756315664.SGD","LU0157215616.USD","XLV","SG9999001176.SGD","IE0002270589.USD","IE00B19Z9P08.USD","BK4532","LU0320765992.SGD","LU0820561909.HKD","PPA","LU0757428866.USD","IDNA","VRTX","AGIO","BIB","IBBQ","LU2417539215.USD","MISL","XBI","LGHT","TBXU","TRUI","LU1084165304.USD","VERX","BBH","PBE","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658918451","title":"Vertex Pharmaceuticals Incorporated : Bofa Global Research Adds Stock to Its US 1 List","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918451?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:47","pubTimestamp":1786452456,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN448154:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIB","IBBQ","IE0009355771.USD","LU1093756168.USD","IE0002270589.USD","IE00BJT1NW94.SGD","TBXU","LU0823416689.USD","LU1585245621.USD","BK4533","LU1035775433.USD","LU0109394709.USD","LU0889565916.HKD","IE00B19Z9Z06.USD","BK4567","LU0061475181.USD","LU2362541513.USD","BBH","IE00B19Z9P08.USD","LU1674673428.USD","LU2417539215.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","GNMX","SG9999013999.USD","IDNA","BK4139","LU2237438978.USD","LU1093756325.SGD","LU2089984988.USD","LU0289739699.SGD","LU0320765992.SGD","LU2468319806.SGD","LU0417517546.SGD","LU2462157665.USD","LU2324357040.USD","LU0058720904.USD","PBE","IBB","BK4588","LU0256863811.USD","LU0079474960.USD","LU0234570918.USD","VRTX","LU1430594728.SGD","SG9999001176.USD","LU1778281490.HKD","SG9999001176.SGD","IE00BFTCPJ56.SGD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174341976","title":"Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1174341976","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174341976?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:08","pubTimestamp":1786450094,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) has issued a stock trading risk warning announcement, stating that it is a CRO enterprise primarily focused on the research and development of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOY","SBIO","GDOC","APXH","XLVI","LFSC","BK0216","BK4588","600721","GSKH","WRND","BK4585","PBE","IBB","BK0102","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992804","title":"Kailera Therapeutics Names Nur Nicholson Chief Technology Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992804","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992804?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:05","pubTimestamp":1786446310,"startTime":"0","endTime":"0","summary":"Kailera Therapeutics names Nur Nicholson chief technology officerKailera Therapeutics named Nur Nicholson chief technology officer, effective Aug. 31, 2026.Role centers on scaling manufacturing and su","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL2PFshn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4533","LU0320765992.SGD","IE00B894F039.SGD","BMED","LU0889565916.HKD","LU2210149790.SGD","LU2210150020.SGD","LU2095319765.USD","IE00BGHQF748.EUR","PBE","LU0234570918.USD","IE00B19Z9Z06.USD","OZEM","SG9999014021.USD","BK4588","NDAQ","BK4585","IE00BKPKM429.USD","KLRA","BIIB","IE00B64PRP62.GBP","LU0314104364.USD","BK4532","IE00B19Z9P08.USD","BCDF","BK4139","SG9999014039.USD","LU0109394709.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}